Cutaneous adverse effects during vemurafenib therapy in metastatic malignant melanoma

被引：1
|
作者：
Martinez Peinado, Carmen [1 ]
Ruiz Villaverde, Ricardo [2 ]
Galan Gutierrez, Manuel [1 ]
Devictoria Munoz, Jose Maria Martinez [3 ]
Garrido Colmenero, Cristina [2 ]
Blasco Morente, Gonzalo [2 ]
机构：
[1] Complejo Hosp Jaen, UGC Dermatol CMA, Jaen, Spain
[2] Hosp Virgen de las Nieves, Serv Dermatol, Granada, Spain
[3] Complejo Hosp Jaen, Serv Anat Patol, Jaen, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
331
引用
收藏
页码：AB167 / AB167
页数：1
相关论文
共 50 条
  • [1] Cutaneous Adverse Effects of BRAF Inhibitor Therapy in Metastatic Malignant Melanoma
    Vanneste, L.
    Wolter, P.
    Garmyn, M.
    Stas, M.
    van den Oord, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 51 - 51
  • [2] Cutaneous Manifestations of Vemurafenib Therapy for Metastatic Melanoma
    Owen, Joshua L.
    Lopez, Isha E.
    Desai, Seemal R.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (05) : 509 - 510
  • [3] Cutaneous side-effects during therapy of melanoma by vemurafenib
    Ankudowicz, Anna
    Brzezicka-Ciach, Urszula
    Wenska, Bozena
    PRZEGLAD DERMATOLOGICZNY, 2015, 102 (03): : 221 - 226
  • [4] Cutaneous Adverse Events during Vemurafenib Therapy
    Chandrakumar, Shivani Felicia
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2014, 18 (04) : 223 - 228
  • [5] Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy
    Maleka, Aglaia
    Enblad, Gunilla
    Sjors, Gunnar
    Lindqvist, Anna
    Ullenhag, Gustav J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : E192 - E193
  • [6] Development of primary malignant Melanoma during therapy with Vemurafenib
    Eleftheriadis, Vlasios
    Boettjer, Joerg
    Stadler, Rudolf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 695 - 695
  • [7] Vemurafenib in patients with metastatic malignant melanoma.
    Ocvirk, Janja
    Mesti, Tanja
    Boc, Marko
    Rebersek, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Intermittent vemurafenib therapy in malignant melanoma
    Treiber, Nicolai
    Huber, Margit Anna
    Schneider, Lars Alexander
    Scharffetter-Kochanek, Karin
    Schultz, Erwin
    Debus, Dirk
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (04): : 450 - 453
  • [9] Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study
    Dika, Emi
    Ravaioli, Giulia Maria
    Piraccini, Bianca Maria
    Lambertini, Martina
    Chessa, Marco Adriano
    Baraldi, Carlotta
    Ribero, Simone
    Andrea, Ardizzoni
    Melotti, Barbara
    Patrizi, Annalisa
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (03) : 266 - 270
  • [10] Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study
    Emi Dika
    Giulia Maria Ravaioli
    Pier Alessandro Fanti
    Bianca Maria Piraccini
    Martina Lambertini
    Marco Adriano Chessa
    Carlotta Baraldi
    Simone Ribero
    Ardizzoni Andrea
    Barbara Melotti
    Annalisa Patrizi
    European Journal of Dermatology, 2017, 27 : 266 - 270
12345